ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.

Recommendations for anticoagulant prophylaxis for pediatric patients at risk for venous thromboembolism (VTE) have been presented.

Cancer patients face a high risk for infection when undergoing cytotoxic chemotherapy and hematopoietic stem cell transplant (HSCT), particularly during the period of neutropenia. In this high-risk ...

Lecturer, Department of Medical Education, Northwestern University Feinberg School of Medicine; Senior Infectious Disease Pharmacist; Clinical Manager, Northwestern Memorial Hospital Department of ...

Star Therapeutics, a late clinical-stage biotechnology company focused on the discovery and development of life-changing ...

Awareness of venous thromboembolism has increased considerably. As a result of the Surgeon General's call to action in 2008 to prevent deep-vein thrombosis and pulmonary embolism, programs have been ...

Previous reports suggest a benefit of fluconazole prophylaxis in extremely low birth weight (ELBW) infants <1000 g. Our aim was to evaluate if limiting fluconazole prophylaxis to targeted highest risk ...

Effective strategies are urgently needed to reduce mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding in resource-limited settings. Women with HIV-1 ...

Pharmacy students in the U.S. show limited knowledge of HIV prophylaxis, especially PEP, due to inadequate assessment tools. Pharmacists are pivotal in HIV prevention, but their knowledge of PrEP and ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...